Align Technology is a medical devices business based in the US. Align Technology shares (ALGN) are listed on the NASDAQ and all prices are listed in US Dollars. Align Technology employs 21,670 staff and has a trailing 12-month revenue of around $3.9 billion.
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
| Latest market close | $226.05 |
|---|---|
| 52-week range | $176.34 - $384.90 |
| 50-day moving average | $251.87 |
| 200-day moving average | $266.72 |
| Wall St. target price | $306.33 |
| PE ratio | 38.3136 |
| Dividend yield | N/A (0%) |
| Earnings per share (TTM) | $5.90 |
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $226.05 from 2024-07-25
| 1 week (2024-07-19) | -10.16% |
|---|---|
| 1 month (2024-06-27) | -6.98% |
| 3 months (2024-04-26) | -26.85% |
| 6 months (2024-01-26) | -14.47% |
| 1 year (2023-07-27) | -41.33% |
|---|---|
| 2 years (2022-07-27) | -13.92% |
| 3 years (2021-07-27) | 625.51 |
| 5 years (2019-07-26) | 13.68% |
Valuing Align Technology stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Align Technology's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Align Technology's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 38x. In other words, Align Technology shares trade at around 38x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
Align Technology's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 1.9618. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Align Technology's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Align Technology's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $820.2 million.
The EBITDA is a measure of a Align Technology's overall financial performance and is widely used to measure a its profitability.
| Revenue TTM | $3.9 billion |
|---|---|
| Operating margin TTM | 17.32% |
| Gross profit TTM | $2.6 billion |
| Return on assets TTM | 6.95% |
| Return on equity TTM | 12.09% |
| Profit margin | 11.34% |
| Book value | $49.98 |
| Market Capitalization | $17 billion |
TTM: trailing 12 months
We're not expecting Align Technology to pay a dividend over the next 12 months.
Over the last 12 months, Align Technology's shares have ranged in value from as little as $176.34 up to $384.9. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Align Technology's is 1.659. This would suggest that Align Technology's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Align Technology, Inc. designs, manufactures, and markets Invisalign clear aligners, and iTero intraoral scanners and services for orthodontists and general practitioner dentists in the United States, Switzerland, and internationally. The company's Clear Aligner segment offers comprehensive products, including Invisalign comprehensive package that addresses the orthodontic needs of younger patients, such as mandibular advancement, compliance indicators, and compensation for tooth eruption; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients generally between the ages of six and ten years, which is a mixture of primary/baby and permanent teeth. The segment also provides Invisalign moderate, lite and express packages, and Invisalign go and Invisalign Go Plus; retention products, Invisalign training, and adjusting tools used by dental professionals during the course of treatment; and Invisalign Palatal Expander, a 3D printed orthodontic device; and 3D printing solutions. Its Imaging Systems and CAD/CAM Services segment offers iTero intraoral scanning system, a single hardware platform for restorative or orthodontic procedures; restorative software for general practitioner dentists, prosthodontists, periodontists, and oral surgeons; and orthodontists software for digital records storage, orthodontic diagnosis, and fabrication of printed models and retainers. This segment also provides Invisalign outcome simulator, a chair-side and cloud-based application for the iTero scanner; Invisalign progress assessment tool; Align Oral Health Suite, a digital interface designed to enhance dental consultations; and TimeLapse technology, which allows doctors or practitioners to compare a patient's historic 3D scans to the present-day scan, as well as subscription software, disposables, rentals, leases, pay per scan, and CAD/CAM software solutions. The company was incorporated in 1997 and is headquartered in Tempe, Arizona.
Trade commission-free stocks and ETFs with Opto, and stay ahead by spotting emerging trends through thematic investing.
Check out our picks of the best paper trading platforms to practice trading and investing with fake money.
Learn the basics of put options: what they are, how they work and a few examples.
Check out our picks for the brokers with the best cash sweep rates on uninvested cash.
These are the best day trading platforms, according to Finder’s comprehensive analysis.
Explore the best bonuses for opening a new brokerage account.
Looking for a discount broker like Webull that offers something different? Here are some of the top alternatives to consider.
What you need to know about investing in the leading indicator for the overall US stock market.
Check out our 7 ideas for how to invest $10K to maximize your money.
Check out the best-performing ETFs so far in 2024.